Volunteers aged 56+ needed for next phase of trials on Qld COVID-19 vaccine
Recruitment begins today for another 96 Queensland volunteers who are 56 and over to trial The University of Queensland’s (UQ) promising COVID-19 vaccine.
Clinical trial specialist Nucleus Network is looking for more healthy volunteers over the age of 56 years to take part in an expansion of the Phase 1 clinical trial.
The Phase 1 trial is about testing the vaccine’s ability to safely stimulate the immune response.
With coronavirus on the increase worldwide, a vaccine is a vital step for returning to a pre-COVID lifestyle.
The Nucleus Network trial is an important part of the UQ vaccine’s development.
Phase 1 clinical trials began on 13 July 2020 with volunteers aged between 18 and 55 years.
With COVID-19 appearing to be more severe in older individuals, more testing will ensure the vaccine is safe for use in older people.
So far, pre-clinical testing of UQ’s vaccine has produced positive indications about its potential effectiveness and manufacturability.
The Phase 1 trial will help the researchers understand more about how different people respond to the vaccine.
The volunteers will play a key role in potentially protecting millions of people worldwide.
Volunteers go through a medical screening process to ensure they are eligible before they are selected to participate in the trial.
To find how you can volunteer, visit the Participate in The COVID-19 Vaccine Study page.
Frequently asked questions (PDF) for participating in a COVID-19 vaccine trial.